Correlation Between Lineage Cell and Qsam Biosciences
Can any of the company-specific risk be diversified away by investing in both Lineage Cell and Qsam Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lineage Cell and Qsam Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lineage Cell Therapeutics and Qsam Biosciences, you can compare the effects of market volatilities on Lineage Cell and Qsam Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lineage Cell with a short position of Qsam Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lineage Cell and Qsam Biosciences.
Diversification Opportunities for Lineage Cell and Qsam Biosciences
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Lineage and Qsam is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Lineage Cell Therapeutics and Qsam Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qsam Biosciences and Lineage Cell is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lineage Cell Therapeutics are associated (or correlated) with Qsam Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qsam Biosciences has no effect on the direction of Lineage Cell i.e., Lineage Cell and Qsam Biosciences go up and down completely randomly.
Pair Corralation between Lineage Cell and Qsam Biosciences
If you would invest 449.00 in Qsam Biosciences on August 29, 2024 and sell it today you would earn a total of 0.00 from holding Qsam Biosciences or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 4.35% |
| Values | Daily Returns |
Lineage Cell Therapeutics vs. Qsam Biosciences
Performance |
| Timeline |
| Lineage Cell Therapeutics |
| Qsam Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lineage Cell and Qsam Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lineage Cell and Qsam Biosciences
The main advantage of trading using opposite Lineage Cell and Qsam Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lineage Cell position performs unexpectedly, Qsam Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qsam Biosciences will offset losses from the drop in Qsam Biosciences' long position.| Lineage Cell vs. MAIA Biotechnology | Lineage Cell vs. Armata Pharmaceuticals | Lineage Cell vs. Portage Biotech | Lineage Cell vs. Cadrenal Therapeutics, Common |
| Qsam Biosciences vs. Lineage Cell Therapeutics | Qsam Biosciences vs. Cadrenal Therapeutics, Common | Qsam Biosciences vs. ImmuCell | Qsam Biosciences vs. Oxford Nanopore Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |